Tulsi Gabbard Resigns as US Intelligence Chief to Support Husband with Rare Bone Cancer Analyst Report Highlights Pinterest Incs Market Prospects Ofcom Flags Child Safety Concerns on TikTok and YouTube Regulatory Risks May Intensify Ubisoft Shares Dip as Assassins Creed Developer Warns of Continuing Losses Trump Asks Supreme Court to Intervene Requesting Pause on TikTok Ban SpaceX Goes Public The Critical Milestone for a Potential 15 Trillion Valuation NiSource NI Q1 2026 Earnings EPS Falls Short But Stock Gains on Operational Resilience COLD Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Progress Evercore Q1 2026 Earnings Blowout EPS Beats Estimates by 4665 TRS Q1 2026 Earnings EPS Surges Past Consensus Shares Gain 26 CLLS Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Despite No Revenue Eton Pharmaceuticals Q1 2026 Earnings EPS Miss Triggers Stock Decline Blue Water Acquisition Corp III BLUW Holds Steady Near NAV Amid Quiet Trading Enova International ENVA Declines 175 as Stock Holds Between Key Support and Resistance Kyverna Therapeutics KYTX Faces Selling Pressure as Stock Nears Key Support at 824 TPG Mortgage Investment Trust MITT Consolidates Near 763 as Support and Resistance Levels Hold BlackRock Taxable Municipal Bond Trust BBN Shows Modest Uptick as Price Hovers Near Midpoint of Key Range Broadridge Financial Stock Outlook Analyst Sentiment Remains Cautiously Optimistic CPSH Q1 2026 Earnings EPS Misses Estimates Amid Revenue Disclosure Gap Natuzzi SpA NTZ Holds Steady at 255 as Traders Eye Resistance GEL Q1 2026 Earnings EPS Misses Estimates Sharply Units Decline Oxford Square Capital Corp Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Declines Life Time Group Holdings LTH Q1 2026 Earnings EPS Beats Estimates as Membership Trends Strengthen Stock Slips AMP Q1 2026 Earnings EPS Beats Estimates by 923 as Wealth Management Segment Drives Results Sachem Capital Corp SCCF Q4 2025 Earnings EPS Surges Past Estimates Notes Edge Higher CVR Energy Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Refining Headwinds Persist Armata Pharmaceuticals Q1 2026 Earnings Significant EPS Miss but Stock Rises on Pipeline Progress